Friday, August 12, 2011

NMBW: 'Two New Mexico startups to present at investor conference'

Quoting from yesterday's posting:

"Two local startups, Avisa Pharma Inc. and Azano Pharmaceuticals, were among 30 companies selected to present at the Rocky Mountain Life Science Investor & Partnering Conference in Denver Sept. 21-22.

The two companies are developing and marketing new technologies licensed from the University of New Mexico to help cystic fibrosis and lupus patients."

Link to New Mexico Business Weekly

Wednesday, August 10, 2011

Daily Camera: "11 Boulder-area companies presenting at bioscience conference"

Quoting from the article by Alicia Wallace:

"Eleven companies from Boulder and Broomfield counties will present at the upcoming Rocky Mountain Life Science Investor and Partnering Conference in Denver, officials for the Colorado BioScience Association announced Tuesday.

The local firms will be among 30 companies to make presentations to industry investors and executives at the event scheduled for Sept. 21 and 22 at the Brown Palace Hotel, 321 17th St., in Denver. The companies and the attendees hail from Colorado, Arizona, Montana, New Mexico, Oklahoma, Utah and Canada."

Link to dailycamera.com

Tuesday, August 9, 2011

Thirty Regional Companies Selected to Present at the 2011 Rocky Mountain Life Science Investor & Partnering Conference in Denver

The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO.

Link to the Business Wire

Link to the Pitch Engine Social Media Newswire

Thursday, August 4, 2011

CBSA Perspective: "Roche site in Boulder to be sold, operated as Corden Pharma"

Quoting from the Alicia Wallace report in the Boulder Daily Camera:

"The 265-person Roche Colorado site in Boulder is expected to be sold to International Chemical Investors Group, officials for both companies announced Wednesday....

'What's nice is it's such a specialized technical facility' that Roche still needs, said Holli Reibel, president and CEO of the Colorado BioScience Association. 'And (Corden) might really bring more product to the plant, which is excellent for Colorado.'

More and more, Reibel added, biotech and pharmaceutical companies have made moves to focus on their core capabilities and have opted to outsource manufacturing efforts elsewhere -- sometimes overseas. Corden Pharma, being a large contract manufacturer with an international reach, should be a welcome addition to Colorado's bioscience community, she said."

Link to the dailycamera.com coverage

Monday, July 11, 2011

DBJ Premium Content: "Working from home? - Be aware of liability issues before they sideline your business"

Quoting from the July 8th Denver Business Journal section, The Home Office:

“'It’s peace of mind,' Maggie Chamberlin Holben said of why she has liability coverage. Her insurance costs about $250 a year, and the home-based public relations consultant doesn’t have to worry if someone trips over her tripod while she’s recording video for a client...Holben has had clients, often those who receive state or federal funds, who require she carry liability insurance. She’s even gone so far as to get professional liability insurance, or an errors and omissions policy.

Her carrier requires that she indemnify herself in each contract, and the insurance is costly — several thousand dollars a year — but again, she said, it goes back to peace of mind."

Link to the Denver Business Journal article by Amy Bryer

Friday, April 8, 2011

Colorado BioScience Association Names Steve Orndorff Board Chair and Appoints Four New Board Members at 2011 Annual All-Member Meeting

Steve Orndorff, Ph.D., CEO of Ariel Pharmaceuticals - http://arielpharma.com - was named chairperson of the board of directors for the Colorado BioScience Association (CBSA) at its 2011 Annual All-Member meeting held at the Colorado National Golf Club facilities in Erie, CO, yesterday. The announcement is made by Holli Baumunk, CBSA President & CEO, who says Orndorff assumes chairperson responsibilities from Rick Jory, CEO of Sandhill Scientific - http://www.sandhillsci.com -Highlands Ranch.

Newly appointed CBSA board members include: * Jeff Castleberry, COO, EndoShape, Inc. - http://endoshape.com * Joe Guiles, Ph.D., Executive Director, MicroRx, CSU Ventures – http://www.microrx.org * Scott Hutton, Sr. Director of Global Marketing, Medtronic Navigation – http://www.medtronic.com/for-healthcare-professionals/business-unit-landing-Page/Navigation * David Mitchell, Executive Director, Plant Manager, Merck & Co., Inc. – http://www.merck.com

Link to the Business Wire Release

Sunday, March 27, 2011

BioBoulder is Tuesday, March 29 - Don't Miss It!

Quoting from the Boulder County Business Report:

"The Colorado BioScience Association is hosting BioBoulder from 5:30 to 7 p.m. on Tuesday, March 29, at Laudisio Italian Restaurant, 1710 29th St. in Boulder. Join colleagues in biotechnology, medical device, biofuels and the university community for an open networking event. Admission is free for members and $50 for nonmembers."

Link to register at the CBSA website

Link to the Boulder County Business Report